BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23835929)

  • 1. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.
    Pomykala KL; Ganz PA; Bower JE; Kwan L; Castellon SA; Mallam S; Cheng I; Ahn R; Breen EC; Irwin MR; Silverman DH
    Brain Imaging Behav; 2013 Dec; 7(4):511-23. PubMed ID: 23835929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
    Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
    Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
    Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
    J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.
    Silverman DH; Dy CJ; Castellon SA; Lai J; Pio BS; Abraham L; Waddell K; Petersen L; Phelps ME; Ganz PA
    Breast Cancer Res Treat; 2007 Jul; 103(3):303-11. PubMed ID: 17009108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients.
    Baudino B; D'agata F; Caroppo P; Castellano G; Cauda S; Manfredi M; Geda E; Castelli L; Mortara P; Orsi L; Cauda F; Sacco K; Ardito RB; Pinessi L; Geminiani G; Torta R; Bisi G
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):559-68. PubMed ID: 23172518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
    Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
    Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study.
    Dumas JA; Makarewicz J; Schaubhut GJ; Devins R; Albert K; Dittus K; Newhouse PA
    Brain Imaging Behav; 2013 Dec; 7(4):524-32. PubMed ID: 23852814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.
    Askren MK; Jung M; Berman MG; Zhang M; Therrien B; Peltier S; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
    Breast Cancer Res Treat; 2014 Sep; 147(2):445-55. PubMed ID: 25138546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.
    Deprez S; Amant F; Smeets A; Peeters R; Leemans A; Van Hecke W; Verhoeven JS; Christiaens MR; Vandenberghe J; Vandenbulcke M; Sunaert S
    J Clin Oncol; 2012 Jan; 30(3):274-81. PubMed ID: 22184379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.
    de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; van Dam FS; Nederveen AJ; Boven E; Schagen SB
    Hum Brain Mapp; 2011 Aug; 32(8):1206-19. PubMed ID: 20669165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain vulnerability to chemotherapy toxicities.
    Ahles TA
    Psychooncology; 2012 Nov; 21(11):1141-8. PubMed ID: 23023994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity.
    Shi DD; Huang YH; Lai CSW; Dong CM; Ho LC; Wu EX; Li Q; Wang XM; Chung SK; Sham PC; Zhang ZJ
    Mol Neurobiol; 2019 Mar; 56(3):2234-2243. PubMed ID: 30008071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy.
    Inagaki M; Yoshikawa E; Matsuoka Y; Sugawara Y; Nakano T; Akechi T; Wada N; Imoto S; Murakami K; Uchitomi Y
    Cancer; 2007 Jan; 109(1):146-56. PubMed ID: 17131349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study.
    López Zunini RA; Scherling C; Wallis N; Collins B; MacKenzie J; Bielajew C; Smith AM
    Brain Imaging Behav; 2013 Dec; 7(4):460-77. PubMed ID: 23242968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.
    Liu L; Mills PJ; Rissling M; Fiorentino L; Natarajan L; Dimsdale JE; Sadler GR; Parker BA; Ancoli-Israel S
    Brain Behav Immun; 2012 Jul; 26(5):706-13. PubMed ID: 22406004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
    Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
    Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment associated with adjuvant therapy in breast cancer.
    Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM
    Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.
    Patel SK; Wong AL; Wong FL; Breen EC; Hurria A; Smith M; Kinjo C; Paz IB; Kruper L; Somlo G; Mortimer JE; Palomares MR; Irwin MR; Bhatia S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26101331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.